# Werfen and Instrumentation Laboratory acquire Accriva Diagnostics

Werfen and its subsidiary Instrumentation Laboratory acquired all shares of Accriva Diagnostics, a point-of-care diagnostic company. The transaction closed on January 19, 2017. Accriva will operate from its San Diego facility.

- Type: Acquisition
- Announced: 2017-01-20
- Where: San Diego, California, USA, United States
- Jobs: 460
- Status: completed
- Products: point-of-care diagnostic products for coagulation and anti-platelet therapy response
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Werfen](https://endata.com/companies/21583.md) (acquirer)
- [Instrumentation Laboratory](https://endata.com/companies/21584.md) (acquirer)
- [Accriva Diagnostics](https://endata.com/companies/21585.md) (target)

## Sources

- [baycitycapital.com](http://baycitycapital.com/portfolio-news/accriva-diagnostics-acquired-by-werfen-and-instrumentation-laboratory-2/), 2017-01-20: "Accriva Diagnostics, a Warburg Pincus portfolio company, announced today the definitive agreement with Werfen... whereby Werfen and IL have acquired all shares of Accriva."
- [biospace.com](https://www.biospace.com/werfen-group-release-company-and-instrumentation-laboratory-company-acquire-accriva-diagnostics-expanding-leadership-in-point-of-care-testing), 2017-01-20: "Werfen and its subsidiary Instrumentation Laboratory (IL) today announced the acquisition of Accriva Diagnostics, a global leader in in vitro diagnostic (IVD) blood testing at the Point-of-Care (POC), including its flagship product portfolio spanning coagulation, platelet aggregation, CO-Oximetry an"
- [nsmedicaldevices.com](https://www.nsmedicaldevices.com/news/werfen-instrumentation-laboratory-acquire-accriva-diagnostics-230117-5721852/), 2017-01-23: "The acquisition of Accriva strengthens our leadership in Hemostasis, Critical Care and Patient Blood Management testing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.